|
Market Closed -
Nasdaq
01:30:00 28/08/2026 am IST
|
After hours 03:14:53 am | |||
| 142.77 USD | -4.60% |
|
142.00 | -0.54% |
| 03:12am | US FDA approves updated COVID vaccines for 2026-27 season | RE |
| 02:50am | FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech | DJ |
| Market Cap | 5.97TCr 5.13TCr 4.8TCr 4.4TCr 8.28TCr 5,70700Cr 8.31TCr 57TCr 22TCr 2,87600Cr 22TCr 22TCr 9,51900Cr | P/E 2026 * |
-17.7x | P/E 2027 * | -30.1x |
|---|---|---|---|---|---|
| Enterprise Value | 5.61TCr 4.82TCr 4.51TCr 4.13TCr 7.78TCr 5,35800Cr 7.8TCr 53TCr 21TCr 2,70000Cr 21TCr 21TCr 8,93700Cr | EV / Sales 2026 * |
26.6x | EV / Sales 2027 * | 23.2x |
| Free-Float |
92.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Moderna, Inc.
| 1 day | -4.91% | ||
| 1 week | -18.13% | ||
| Current month | +160.43% | ||
| 1 month | +164.05% | ||
| 3 months | +203.57% | ||
| 6 months | +176.10% | ||
| Current year | +384.13% |
| 1 week | 130 | 161.37 | |
| 1 month | 52.66 | 176.66 | |
| Current year | 29.81 | 176.66 | |
| 1 year | 22.28 | 176.66 | |
| 3 years | 22.28 | 176.66 | |
| 5 years | 22.28 | 464.85 | |
| 10 years | 11.54 | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/08/26 | Fiscal year | Chief Executive Officer | 5,04,938 | 0.1273% | ||
| 15/07/26 | Fiscal year | Chairperson | 1,60,008 | 0.0403% | ||
| 08/07/26 | Free | Director | 14,766 | 0.0037% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.60% | -18.13% | +477.32% | +27.55% | 5.97TCr | ||
| -0.87% | -3.94% | +37.45% | -2.73% | 8.14TCr | ||
| +0.84% | +4.44% | -19.19% | -35.11% | 5.92TCr | ||
| +0.76% | +3.53% | +0.08% | +36.18% | 5.33TCr | ||
| +0.41% | +1.88% | +11.09% | +171.67% | 4.91TCr | ||
| +0.19% | -0.03% | +62.01% | -16.23% | 3.27TCr | ||
| -0.30% | -0.57% | +52.07% | +100.03% | 2.6TCr | ||
| -2.00% | +9.52% | +12.38% | +218.34% | 2.44TCr | ||
| +0.78% | +0.47% | +61.53% | +123.40% | 1.69TCr | ||
| -4.68% | +2.52% | -9.33% | +752.25% | 1.56TCr | ||
| Average | -0.98% | -0.46% | +68.54% | +137.54% | 4.18TCr | |
| Weighted average by Cap. | -0.87% | -1.34% | +85.00% | +73.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 210.6Cr 180.78Cr 169.25Cr 154.98Cr 291.95Cr 20TCr 292.78Cr 2TCr 783.47Cr 10TCr 790.71Cr 773.63Cr 34TCr | 247.57Cr 212.52Cr 198.96Cr 182.19Cr 343.2Cr 24TCr 344.18Cr 2.36TCr 921Cr 12TCr 929.51Cr 909.44Cr 39TCr |
| Net income | -331.71Cr -284.74Cr -266.58Cr -244.1Cr -459.84Cr -32TCr -461.14Cr -3.16TCr -1.23TCr -16TCr -1.25TCr -1.22TCr -53TCr | -193.43Cr -166.04Cr -155.45Cr -142.34Cr -268.15Cr -18TCr -268.91Cr -1.84TCr -719.58Cr -9.31TCr -726.24Cr -710.55Cr -31TCr |
| Net Debt | -364.91Cr -313.24Cr -293.26Cr -268.53Cr -505.86Cr -35TCr -507.29Cr -3.47TCr -1.36TCr -18TCr -1.37TCr -1.34TCr -58TCr | -219.36Cr -188.3Cr -176.29Cr -161.43Cr -304.1Cr -21TCr -304.96Cr -2.09TCr -816.05Cr -11TCr -823.6Cr -805.81Cr -35TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $142.77 | -4.60% | 2,49,22,736 |
| 26/26/26 | $149.66 | -5.77% | 2,20,09,462 |
| 25/26/25 | $158.83 | +14.36% | 4,92,25,650 |
| 24/26/24 | $138.89 | -4.30% | 3,15,87,240 |
| 21/26/21 | $145.13 | +8.86% | 8,73,16,065 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions


















